Robert Torray
Torray Fund
Torray Fund Johnson & Johnson stake
total: 71
Torray Fund JNJ trades
- Total transactions:
- 8
- New positions:
- 1
- Sold out:
- 1
- Added:
- 2
- Reduced:
- 4
- Held since:
- 2020 Q1
- Held for:
- 21 quarters
- Latest activity:
- 2025 Q2
According to 2026 Q1 report, Torray Fund doesn't hold any Johnson & Johnson (JNJ) shares. To date, the estimated cost basis is nearly $138.77 for "buy" trades and estimated average "sell" price is $167.15. Torray Fund first purchased JNJ in 2020 Q1, initially acquiring 108,924 shares. Since the initial investment in Johnson & Johnson (JNJ), Torray Fund has made 7 more transactions.
When did Torray Fund sell Johnson & Johnson (JNJ)?
Torray Fund sold off the entire Johnson & Johnson (JNJ) position in 2025 Q2.
When did Torray Fund buy Johnson & Johnson (JNJ)?
Torray Fund first invested in Johnson & Johnson (JNJ) in 2020 Q1 at the reported quarter-end price of $131.13 per share.
What's the cost basis of Torray Fund's JNJ stake?
The estimated cost basis for Johnson & Johnson (JNJ) stake is around $138.77 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $138.77
- Weighted AVG sell price:
- $167.15
Torray Fund's historical trades in Johnson & Johnson
8 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q2
|
0.00%
|
0
|
$165.02
|
|
-100% (-105,365)
|
-5.02%
|
|
2024 Q3
|
4.92%
|
105,365
|
$165.86
|
$17,475,839
|
+26.64% (+22,165)
|
+1.04%
|
|
2024 Q1
|
3.90%
|
83,200
|
$161.38
|
$13,426,816
|
+14.05% (+10,250)
|
+0.48%
|
|
2022 Q2
|
4.27%
|
72,950
|
$177.51
|
$12,949,354
|
-15.13% (-13,007)
|
-0.65%
|
|
2022 Q1
|
4.27%
|
85,957
|
$177.23
|
$15,234,159
|
-9.12% (-8,625)
|
-0.4%
|
|
2021 Q4
|
4.29%
|
94,582
|
$171.07
|
$16,180,143
|
-8.47% (-8,758)
|
-0.41%
|
|
2021 Q3
|
4.51%
|
103,340
|
$161.50
|
$16,689,410
|
-5.13% (-5,584)
|
-0.23%
|
|
2020 Q1
|
4.84%
|
$131.13
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.